$ANAC Anacor Pharmaceuticals, Inc. Insider Trading Week 50/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Anacor Pharmaceuticals, Inc. in week 50/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 5.59 | 14,000 | 78,260 | 27,661 | |
| Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 114.99 | 100 | 11,499 | 28,747 | 28.8 K to 28.7 K (-0.35 %) |
| Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 113.79 | 2,896 | 329,524 | 28,847 | 31.7 K to 28.8 K (-9.12 %) |
| Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 113.14 | 9,430 | 1,066,944 | 31,743 | 41.2 K to 31.7 K (-22.90 %) |
| Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 112.06 | 1,574 | 176,379 | 41,173 | 42.7 K to 41.2 K (-3.68 %) |
| Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 5.59 | 14,000 | 78,260 | 42,747 | 28.7 K to 42.7 K (+48.70 %) |
| Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 111.25 | 900,000 | 100,125,000 | 325,535 | 1.2 M to 325.5 K (-73.44 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 21.21 | 6,000 | 127,260 | 294,000 | |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.20 | 14,000 | 72,800 | 0 | |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 118.59 | 500 | 59,294 | 254,760 | 255.3 K to 254.8 K (-0.20 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 117.60 | 8,178 | 961,744 | 255,260 | 263.4 K to 255.3 K (-3.10 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 117.04 | 10,732 | 1,256,050 | 263,438 | 274.2 K to 263.4 K (-3.91 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 115.52 | 590 | 68,159 | 274,170 | 274.8 K to 274.2 K (-0.21 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 21.21 | 6,000 | 127,260 | 274,760 | 268.8 K to 274.8 K (+2.23 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.20 | 14,000 | 72,800 | 268,760 | 254.8 K to 268.8 K (+5.50 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 117.36 | 40,000 | 4,694,400 | 33,886 | 73.9 K to 33.9 K (-54.14 %) |